CYNTHIA RAGSDALE: Open Payments
NPI 1639559149 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 36 payments from 12 companies in 2025. Trend: 2023 $1,531 · 2024 $1,597 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $255 |
| Janssen Biotech, Inc. | 4 | $76 |
| Ardelyx, Inc. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $23 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $21 |
Products named: RINVOQ, TREMFYA, CREON, Linzess, IBSRELA, XIFAXAN, ZENPEP, SKYRIZI.
Industry payments across GA — which companies pay providers there.
